Thus, we aimed to monitor its methylation status and its impact on the response elements within HeyL promoter in COVID-19 patients and, in addition to, study its correlation with the clinical outcomes and the routine biomarkers including PLR, CRP, ferritin and D-dimer. This evidence concerns the gene CRP and COVID-19.